Array Technologies, Inc. Reports Financial Results for the First Quarter 2022 – Delivers strong top-line growth, a robust backlog and continued margin progression in the legacy Array business
Go back to Array Technologies, Inc. Reports Financial Results for the First Quarter 2022 – Delivers strong top-line growth, a robust backlog and continued margin progression in the legacy Array business| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 7.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.90 | 52 Week High | $7.27 | |||
| Open | $7.90 | 52 Week Low | $2.39 | |||
| Day High | $7.90 | P/E | N/A | |||
| Day Low | $7.90 | EPS | $-0.61 | |||
| Volume | 18 | |||||
